Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Stock Traders Daily
$20.00
Provider: Pechala's Reports
$25.00
Provider: Pechala's Reports
$15.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Corgenix Medical Corp Announces Diagnostic Development Agreement With Eli Lilly and Company


Wednesday, 22 May 2013 06:45am EDT 

Corgenix Medical Corp announced that it has entered into a collaboration agreement with Eli Lilly and Company to develop diagnostic technology in support of a Lilly oncology pipeline program. Under the terms of the agreement, the two companies will collaborate to further advance this diagnostic technology originally developed by Lilly. The financial terms of the agreement were not disclosed. 

Latest Key Developments in Pharmaceuticals

Company Quote

62.84
0.31 +0.50%
11 Jul 2014